A prospective study of hypertension and risk of uterine leiomyomata

American Journal of Epidemiology

Volumn 161, Issue 7, 2005, Pages 628-638

  Boynton Jarrett, Renée ^a   Rich Edwards, Janet ^a,b   Malspeis, Susan ^a,c   Missmer, Stacey A ^a,c   Wright, Rosalind ^c,d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d CHANNING LABORATORY   (United States)

Author keywords

Blood pressure; Cohort studies; Hypertension; Leiomyoma; Uterine diseases; Uterine neoplasms

Indexed keywords

ANTIHYPERTENSIVE AGENT; ORAL CONTRACEPTIVE AGENT;

HYPERTENSION;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; HYSTERECTOMY; INCIDENCE; MAJOR CLINICAL STUDY; MYOMETRIUM; NURSE; PREMENOPAUSE; PROSPECTIVE STUDY; REPRODUCTION; RISK FACTOR; ULTRASOUND; UNITED STATES; UTERUS MYOMA; WELLBEING;

ADULT; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; LEIOMYOMA; NURSES; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES; UTERINE NEOPLASMS;

EID: 15744362713     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwi072     Document Type: Article

References (89)

1. Ross R, Pike MC, Vessey MP, et al. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J 1986;293:359-62.
2. Vollenhoven B. Introduction: the epidemiology of uterine leiomyomas. Baillieres Clin Obstet Gynaecol 1998;12:169-76.
3. Newbold RR, DiAugustine RP, Risinger JI, et al. Advances in uterine leiomyoma research: conference overview, summary, and future research recommendations. Environ Health Perspect 2000;108:769-73.
4. Cramer SF, Horiszny JA, Leppert P. Epidemiology of uterine leiomyomas. With an etiologic hypothesis. J Reprod Med 1995;40:595-600.
5. Schwartz SM, Marshall LM, Baird DD. Epidemiologic contributions to understanding the etiology of uterine leiomyomata. Environ Health Perspect 2000;108:821-7.
6. Lepine LA, Hillis SD, Marchbanks PA, et al. Hysterectomy surveillance-United States, 1980-1993. MMWR CDC Surveill Summ 1997;46:1-15.
7. Wilcox L, Koonin LM, Pokras R, et al. Hysterectomy in the United States, 1988-1990. Obstet Gynecol 1994;83:549-55.
8. Xhao SZ, Wong JM, Arguelles LM. Hospitalization costs associated with leiomyoma. Clin Ther 1999;21:563-75.
9. Carlson KJ, Nichols DH, Schiff I. Current concepts: indications for hysterectomy. N Engl J Med 1993;328:856-60.
10. Coronado GD, Marshall LM, Schwartz SM. Complications in pregnancy, labor, and delivery with uterine leiomyomas: a populations-based study. Obstet Gynecol 2000;95:764-9.
11. Carlson KJ, Miller BA, Fowler FJ Jr. The Maine Women's Health Study. II. Outcomes of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain. Obstet Gynecol 1994;83:566-72.
12. Kjerulff KH, Langenberg P, Seidman JD, et al. Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. J Reprod Med 1996;41:483-90.
13. Haney AF. Clinical decision making regarding leiomyomata: what we need in the next millenium. Environ Health Perspect 2000;108:835-9.
14. Buttram VC, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 1981; 36:433-55.
15. Wegienka G, Baird DD, Hertz-Picciotto I, et al. Self-reported heavy bleeding associated with uterine leiomyomata. Obstet Gynecol 2003;101:431-7.
16. Moore JG. Benign diseases of the uterine corpus. In: Hacker NF, Moore JG, eds. Essentials of obstetrics and gynecology. Philadelphia, PA: WB Saunders Company, 1998:412-20.
17. Day Baird D, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003;188: 100-7.
18. Borgfeldt C, Andolf E. Transvaginal ultrasonographic findings in the uterus and the endometrium: low prevalence of leiomyoma in a random sample of women age 25-40 years. Acta Obstet Gynecol Scand 2000;79:202-7.
19. Luoto R, Kaprio J, Rutanen EM, et al. Heritability and risk factors of uterine fibroids-the Finnish Twin Cohort Study. Maturitas 2000;37:15-26.
20. Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990;94:435-8.
21. Marshall L, Spiegelman D, Barbieri R, et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 1997;90:967-73.
22. Faerstein E, Szklo M, Rosenshein N. Risk factors for uterine leiomyoma: a practice-based case-control study. I. African-American heritage, reproductive history, body size, and smoking. Am J Epidemiol 2001;153:1-10.
23. Marshall L, Spiegelman D, Manson J, et al. Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking. Epidemiology 1998; 9:511-17.
24. Okoronkwo MO. Body weight and uterine leiomyomas among women in Nigeria. West Afr J Med 1999;18:52-4.
25. Lumbiganon P, Rugpao S, Phandhu-fung S, et al. Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study. Br J Obstet Gynaecol 1996;103:909-14.
26. Sato F, Nishi M, Kudo R, et al. Body fat distribution and uterine leiomyomas. J Epidemiol 1998;8:176-80.
27. Chiaffarino F, Parazzini F, La Vecchia C, et al. Diet and uterine myomas. Obstet Gynecol 1999;94:395-8.
28. Wong F, Yamada M, Sasaki H, et al. Noncancer disease incidence in the atomic bomb survivors: 1958-1986. Radiat Res 1993;135:418-30.
29. Kawamura S, Kasagi F, Kodama K, et al. Prevalence of uterine myoma detected by ultrasound examination in the atomic bomb survivors. Radiat Res 1997;147:753-8.
30. Van Voorhis BJ, Romitti PA, Jones MP. Family history as a risk factor for development of uterine leiomyomas. Results of a pilot study. J Reprod Med 2002;47:663-9.
31. Vikhlyaeva E, Khodzhaeva ZS, Fantschenko ND. Familial predisposition to uterine leiomyomas. Int J Gynaecol Obstet 1995;51:127-31.
32. Schwartz S, Voigt L, Tickman E, et al. Familial aggregation of uterine leiomyomata. (Abstract). Am J Epidemiol 2000;151 (suppl):S10.
33. Gross K, Morton CC. Genetics and the development of fibroids. Clin Obstet Gynecol 2001;44:335-49.
34. Briggs ND, John CT, Ufomadu L. Is fibroid familial? (Letter). Trop Doct 1993;23:181.
35. Sato F, Mon M, Nishi M, et al. Familial aggregation of uterine myomas in Japanese women. J Epidemiol 2002;12: 249-53.
36. Treloar S, Martin NG, Dennerstein L, et al. Pathways to hysterectomy: insights from longitudinal twin research. Am J Obstet Gynecol 1992;167:82-6.
37. Marshall LM, Spiegelman D, Goldman M, et al. A prospective study of reproductive factors and oral contraceeptive use in relation to the risk of uterine leiomyomata. Fertil Steril 1998;70:432-9.
38. Sato F, Miyake H, Nishi M, et al. Early normal menstrual cycle pattern and the development of uterine leiomyomas. J Womens Health Gend Based Med 2000;9:299-302.
39. Samadi AR, Lee NC, Flanders WD, et al. Risk factors for self-reported uterine fibroids: a case-control study. Am J Public Health 1996;86:858-62.
40. Parazzini F, Negri E, La Vecchia C, et al. Reproductive factors and risk of uterine fibroids. Epidemiology 1996;7:440-2.
41. Baron JA. Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious. Br Med Bull 1996;52:58-73.
42. Parazzini F, Negri E, La Vecchia C, et al. Uterine myomas and smoking. Results from an Italian study. J Reprod Med 1996;41:316-20.
43. Walker CL, Cesen-Cummings K, Houle C, et al. Protective effect of pregnancy for development of uterine leiomyoma. Carcinogenesis 2001;22:2049-52.
44. Chen CR, Buck GM, Courey NG, et al. Risk factors for uterine fibroids among women undergoing tubal sterilization. Am J Epidemiol 2001;153:20-6.
45. Baird D, Danson DB. Why is parity protective for uterine fibroids? Epidemiology 2003;14:247-50.
46. Schwartz SM. Invited commentary: studying the epidemiology of uterine leiomyomata-past, present, and future. Am J Epidemiol 2001;153:27-9.
47. Summers W, Watson RL, Wooldridge WH, et al. Hypertension, obesity and fibromyomata uteri, as a syndrome. Arch Intern Med 1971;128:750-4.
48. Hocutt J. Uterine fibroids and hypertension. Del Med J 1979;51:697-9.
49. Lowell H, Miall WE, Stewart DB. Arterial blood pressure in Jamaican women with and without fibroids. West Indian Med J 1966;15:45-51.
50. Clinch J, Sweetnam P. Fibroids and hypertension. J Obstet Gynaecol Br Commonw 1968;75:1052-3.
51. Everett H, Scott RB. The possible etiologic role of gynecologic lesions in the production of hypertension. Am J Obstet Gynecol 1942;44:1010-25.
52. Moehlig R. Association of uterine fibromyomas with other clinical conditions. J Clin Endocrinol 1942;2:219-22.
53. Aboyeji AP, Ijaiya MA. Uterine fibroids: a ten-year clinical review in Ilorin, Nigeria. Niger J Med 2002;11:16-19.
54. Emembolu JO. Uterine fibromyomata: presentation and management in northern Nigeria. Int J Gynaecol Obstet 1987;25:413-16.
55. Luoto R, Rutanen E, Auvinen A. Fibroids and hypertension: a cross-sectional study of women undergoing hysterectomy. J Reprod Med 2001;46:359-64.
56. Faerstein E, Szklo M, Rosenshein NB. Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation. Am J Epidemiol 2001;153:11-19.
57. Koepsell TD, Weiss NS, Thompson DJ, et al. Prevalence of prior hysterectomy in the Seattle-Tacoma area. Am J Public Health 1980;70:40-7.
58. Luoto R, Kaprio J, Reunanen A, et al. Cardiovascular morbidity in relation to ovarian function after hysterectomy. Obstet Gynecol 1995;85:515-22.
59. Settnes A, Jorgensen T. Hypertension and hysterectomy in Danish women. Obstet Gynecol 1998;92:274-80.
60. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-46.
61. Stamler J. Blood pressure and high blood pressure: aspects of risk. Hypertension 1991;18:I95-107.
62. Benetos A, Thomas F, Bean K, et al. Prognostic value of systolic and diastolic blood pressure in treated hypertensive men. Arch Intern Med 2002;162:577-81.
63. Kannel W, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease: the Framingham Study. Am J Cardiol 1971;27:335-45.
64. Kannel W, Dawber TR, McGee DL. Perspectives on systolic hypertension: the Framingham study. Circulation 1980;61:1179-82.
65. Izzo JL Jr, Levy D, Black HR. Clinical advisory statement. Importance of systolic blood pressure in older Americans. Hypertension 2000;35:1021-4.
66. Franklin S, Martin GL, Kahn SA, et al. Does the relation of blood pressure to coronary heart disease change with aging? The Framingham Heart Study. Circulation 2001;103: 1245-9.
67. Colditz G, Martin P, Stampfer MJ, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 1986;123:894-900.
68. Therneau T. Extending the Cox model. In: Lin D, Fleming TR, ed. Proceedings of the First Seattle Symposium in Biostatistics: survival analysis. New York, NY: Springer Verlag, 1997:51-84.
69. Hertzmark E, Spiegleman D. The SAS MPHREG macro. Boston, MA: Channing Laboratory, 2001.
70. Rothman KJ, Greenland S. Modern epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven, 1998.
71. Hosmer DW, Lemeshow S. Applied logistic regression. New York, NY: John Wiley & Sons, Inc, 1989.
72. Moss N, Benditt EP. Human atherosclerotic plaque cells and leiomyoma cells. Am J Pathol 1975;78:175-90.
73. Nowak RA. Novel therapeutic strategies for leiomyomas: targeting growth factors and their receptors. Environ Health Perspect 2000;108:849-53.
74. Crawford BS, Davis J, Harrigill K. Uterine artery atherosclerotic disease: histologic features and clinical correlation. Obstet Gynecol 1997;90:210-15.
75. Haust M, Las Heras J, Harding P. Fat-containing uterine smooth muscle cells in "toxemia": possible relevance to atherosclerosis? Science 1977;195:1353-4.
76. Sozen I, Arici A. Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata. Fertil Steril 2002;78:1-12.
77. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994;331:1286-92.
78. Kuwahara F, Kai H, Tokuda K, et al. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 2002;106:130-5.
79. Arici A, Sozen I. Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor-beta1 in human myometrium and leiomyoma. Am J Obstet Gynecol 2003;188:76-83.
80. Fukuda N, Hu WY, Kubo A, et al. Abnormal regulation of transforming growth factor-beta receptors on vascular smooth muscle cells from spontaneously hypertensive rats by angiotensin II. Hypertension 1998;31:672-7.
81. Cramer SF, Robertson AL, Ziats NP, et al. Growth potential of human uterine leiomyomas: some in vitro observations and their implications. Obstet Gynecol 1985;66:36-41.
82. Longcope C, Johnston CC Jr. Androgen and estrogren dynamics in pre- and post-menopausal women: a comparison between smokers and nonsmokers. J Clin Endocrinol Metab 1988;67:379-83.
83. MacMahon B, Trichopoulos D, Cole P, et al. Cigarette smoking and urinary estrogens. N Engl J Med 1982;307: 1062-5.
84. Westhoff C, Bentile G, Lee J, et al. Predictors of ovarian steroid secretion in reproductive-age women. Am J Epidemiol 1996;144:381-8.
85. Zumoff B, Miller EH, Heinz U, et al. The effect of smoking on serum progesterone, estradiol, and luteinizing hormone levels over a menstraul cycle in normal women. Steroids 1990; 55:507-11.
86. Fiebach N, Hebert PR, Stampfer MJ, et al. A prospective study of high blood pressure and cardiovascular disease in women. Am J Epidemiol 1989;130:646-54.
87. Anastasiadis PG, Koutlaki NG, Skaphida PG, et al. Endometrial polyps: prevalence, detection, and malignant potential in women with abnormal uterine bleeding. Eur J Gynaecol Oncol 2000;21:180-3.
88. Reslova T, Tosner J, Resl M, et al. Endometrial polyps. A clinical study of 245 cases. Arch Gynecol Obstet 1999; 262:133-9.
89. Baird DD. Invited commentary: uterine leiomyomata-we know so little but could learn so much. Am J Epidemiol 2004;159:124-6.